EUVIMEDEUVIMED entdecken
Open Access

Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy

Linjie Bian, Zheyi Wang, Panli Li, Simin He, Jianping Zhang, Xiaoping Xu, Xiangwei Wang, Shaoli Song

Theranostics · 2025

DOI: 10.7150/thno.117021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Linjie Bian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, shanghai…. Hauptthemen laut MEDLINE: Receptor, Cholecystokinin B, MTOR Inhibitors, TOR Serine-Threonine Kinases, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cholecystokinin BMTOR InhibitorsTOR Serine-Threonine KinasesRadiopharmaceuticalsRadiation-Sensitizing AgentsAnimalsMiceHumansCell Line, TumorLutetiumGallium RadioisotopesRadioisotopesEverolimusLung NeoplasmsCarcinoma, NeuroendocrinePositron-Emission TomographyThyroid NeoplasmsXenograft Model Antitumor AssaysMice, NudeFemaleSmall Cell Lung Carcinoma

Stichwörter der Autor:innen

Multimeric radioligandNeuroendocrine tumorsOxidative stress modulationPeptide receptor radionuclide therapy (PRRT)Radiosensitization

Substanzen

Receptor, Cholecystokinin BMTOR InhibitorsTOR Serine-Threonine KinasesLutetiumGallium RadioisotopesRadioisotopesEverolimusRadiopharmaceuticalsLutetium-177Radiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, shanghai 200032, China.
  • Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai 200032, China.
  • Center for Biomedical Imaging, Fudan University; Shanghai 200032, China.
  • Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Fudan University, Shanghai 200433, China.
  • Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, shanghai 200032, China.
  • Institute of Thoracic Oncology, Fudan University, Shanghai, China.

Zitieren

APA

Bian, L., Wang, Z., Li, P., He, S., Zhang, J., Xu, X., Wang, X., & Song, S. (2025). Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy. Theranostics. https://doi.org/10.7150/thno.117021

Vancouver

Bian L, Wang Z, Li P, He S, Zhang J, Xu X, et al. Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy. Theranostics. 2025. doi:10.7150/thno.117021

BibTeX
@article{Bian2025,
  author = {Bian, Linjie and Wang, Zheyi and Li, Panli and He, Simin and Zhang, Jianping and Xu, Xiaoping and Wang, Xiangwei and Song, Shaoli},
  title = {Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.117021}
}
Kostenlos starten →